Trial Profile
Clinical Trials Insight: 700031707
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 19 Mar 2008
Price :
$35
*
At a glance
- Drugs Lonidamine (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Threshold Pharmaceuticals
- 19 Mar 2008 New trial record.